Greater Bay Initiative - Upping Integration, Part 1
The US-China trade tensions have eased for the moment. But China’s leaders realise that the real war between a rising and an existing economic...
401 Views
Ascentage Pharma (亚盛医药) IPO: Thoughts on Valuation
Ascentage Pharma is pre-marketing the USD 200 - 300 million IPO to list in Hong Kong. In our previous insight, we highlight the company's key...
489 Views
ECM Weekly (22 Jun 2019) - Alibaba, Budweiser Brewing Co, Ascentage, CIMC Vehicle, Impro Precision
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
558 Views
Ascentage Pharma (亚盛医药) IPO: Updates and Thoughts on HQP1351 (3rd Gen Bcr-Abl TKI)
Ascentage Pharma is pre-marketing the USD 200 - 300 million IPO to list in Hong Kong. In our previous insight, we highlight the company's key...
751 Views
Ascentage Pharma (亚盛医药) IPO: Too Early for an IPO
Ascentage Pharma, a China-based biotech company, filed an application to list on the Hong Kong Stock Exchange. In this insight, we will cover the...
1.1k Views